From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Synonyms: chidamide | CS-055 | CS055 | Epidaza® (China) | HBI-8000
tucidinostat is an approved drug (China)
Compound class:
Synthetic organic
Comment: Tucidinostat (chidamide) is an orally active inhibitor of histone deacetylase (HDAC) enzymes [4]. It has some subtype selectivity for HDAC isoenzymes 1, 2, 3 and 10. Note that we show this compound with no specified stereochemistry.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Efficacy of chidamide has been measured using in vitro cytotoxicity, histone acetylation and signalling pathway activation assays. An IC50 or Ki for HDAC inhibition is not available. We have tagged HDAC1 as the pimary molecular target of this drug for data metrics purposes only, and in no way suggest that this in the only target of this drug. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Ligand mentioned in the following text fields |
| Histone deacetylases (HDACs) overview |